Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $143.25 USD
Change Today 0.00 / 0.00%
Volume 0.0
BAYZF On Other Exchanges
Symbol
Exchange
OTC US
Xetra
BrsaItaliana
Xetra
Mexico
Continuous
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYZF) Key Developments

Bayer AG to Early Redeem EUR 1.3 Billion Bond Issued in 2005

Bayer AG plans to early redeem a EUR 1.3 billion bond. The first opportunity to repay the subordinated bond with a 5% coupon and a 100-year maturity issued in 2005 (ISIN XS0225369403) arises on July 29, 2015. The company has decided to utilize this repayment right. The company will arrange for publication of a formal investor notification in the newspaper Luxemburger Wort or through the clearing system in June 2015 in accordance with the bond conditions.

Bayer AG Proposes Dividend for the Year 2014

The Board of Management and the Supervisory Board of Bayer AG propose that the entire distributable profit of EUR 1,860,632,568.00 reported in the annual financial statements for the fiscal year 2014 be used to pay a dividend of EUR 2.25 per share carrying dividend rights, at the AGM to be held on May 27, 2015.

Bayer AG Proposes Amendment to the Articles of Incorporation

Bayer AG proposed amendment of the Object of the company (Section 2, Paragraph 1 of the Articles of Incorporation) to the AGM to be held on May 27, 2015.

Bayer To Sell Oral Contraceptive Pill Operation

South Korea's anti-trust regulator ordered the local subsidiary of Bayer AG (DB:BAYN) to sell its oral contraceptive pill operation that it acquired when its parent bought Merck & Co., citing conflicts with the country's fair trade rules. The Fair Trade Commission (FTC) said it ordered Bayer Korea Ltd. to dispose of its assets and rights related to all Mercilon tablet business in the country. "The decision was made because Bayer's dominance in a market that is already controlled by imported drugs could be detrimental to the interest of consumers," the FTC said, adding that the measure could preempt any moves by Bayer to hike up prices for its drugs.

Bayer Considering Multiple Strategic Alternatives For Home And Garden Consumer Products

Bayer AG (DB:BAYN) is considering multiple strategic alternatives for home and garden consumer products business. Germany's Bayer said it was considering strategic options for its home and garden consumer products business, maker of Baby Bio plant feed, as its crop protection arm focuses on professional customers. "A number of strategic alternatives are under consideration," a spokesman for the diversified drugs and pesticides maker said on March 20, 2015. People familiar with the matter told Reuters that Bayer was preparing to sell the business and was gauging the interest of prospective buyers, which could be private equity or industry players. The business generated €220 million euros in annual sales in 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYZF:US $143.25 USD 0.00

BAYZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $295.37 USD -1.68
Bristol-Myers Squibb Co $65.86 USD +0.51
GlaxoSmithKline PLC 1,585 GBp +3.50
Novo Nordisk A/S kr393.60 DKK +11.30
Sanofi €96.53 EUR +0.37
View Industry Companies
 

Industry Analysis

BAYZF

Industry Average

Valuation BAYZF Industry Range
Price/Earnings 28.8x
Price/Sales 2.3x
Price/Book 4.9x
Price/Cash Flow 28.8x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.